These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3757269)

  • 21. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening.
    Haynes CA; De Jesús VR
    Clin Chim Acta; 2012 Aug; 413(15-16):1217-21. PubMed ID: 22503909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy.
    Tsuji S; Suzuki M; Ariga T; Sekine M; Kuriyama M; Miyatake T
    J Neurochem; 1981 Mar; 36(3):1046-9. PubMed ID: 7205256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
    Tönshoff B; Lehnert W; Ropers HH
    Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
    Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
    Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
    Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
    Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid screening procedure for the diagnosis of peroxisomal disorders: quantification of very long-chain fatty acids, as dimethylaminoethyl esters, in plasma and blood spots, by electrospray tandem mass spectrometry.
    Johnson DW
    J Inherit Metab Dis; 2000 Jul; 23(5):475-86. PubMed ID: 10947202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
    Watkins PA; Naidu S; Moser HW
    J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
    Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
    Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
    Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
    J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
    Tsuji S; Sano-Kawamura T; Ariga T; Miyatake T
    J Neurol Sci; 1985 Dec; 71(2-3):359-67. PubMed ID: 4087029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenoleukodystrophy: fatty acid analysis of total glycerophospholipids in erythrocyte membranes.
    Antoku Y; Sakai T; Goto I; Katafuchi Y; Sato H; Iwashita H; Kuroiwa Y
    Acta Neurol Scand; 1985 Aug; 72(2):193-7. PubMed ID: 4050328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
    Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
    J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
    Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
    Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
    Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
    Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-linked Adrenoleukodystrophy, The Tunisian Experience.
    Nasrallah F; Kraoua I; Zidi W; Omar S; Sanhaji H; Feki M; Ben Youssef IT; Kaabachi N
    Clin Lab; 2015; 61(10):1531-6. PubMed ID: 26642716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I; Moser AE; Moser HW; Kishimoto Y
    Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenoleukodystrophy: a clinical variant presenting as olivopontocerebellar atrophy.
    Ohno T; Tsuchida H; Fukuhara N; Yuasa T; Harayama H; Tsuji S; Miyatake T
    J Neurol; 1984; 231(4):167-9. PubMed ID: 6096516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
    Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
    Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW; Moser AE; Singh I; O'Neill BP
    Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.